Skip to main content
British Journal of Industrial Medicine logoLink to British Journal of Industrial Medicine
. 1987 Mar;44(3):161–174. doi: 10.1136/oem.44.3.161

Mortality of workers employed in two asbestos cement manufacturing plants.

J M Hughes, H Weill, Y Y Hammad
PMCID: PMC1007799  PMID: 3828242

Abstract

In a study of the mortality experience of 6931 employees of two New Orleans asbestos cement products manufacturing plants over 95% were traced. Chrysotile was the primary fibre used in both plants. Plant 1 also used small amounts of amosite and, later, crocidolite irregularly whereas plant 2 used crocidolite steadily in pipe production. Previously reported exposure concentration estimates were revised, based on additional air sampling data and re-evaluation of these data. Workers in the two plants had similar duration of employment (overall, a mean of 3.8 years) and estimated exposure concentration (a mean of 7.6 million particles per cubic foot (mppcf)). Mortality was similar for these plants and comparable with Louisiana rates for all causes combined, nonmalignant causes, and primary cancers of specified sites other than lung. Short term workers from both plants showed raised and similar risk of lung cancer, but risk among longer term workers differed--for example, for workers employed over one year there was no excess in plant 1 (16 observed, 17.2 expected) but a significant excess in plant 2 (52 observed, 28.9 expected, p less than 0.001). After excluding short term workers, risk of lung cancer in plant 2 showed a significant trend with estimated cumulative asbestos exposure; using a conversion of 1.4 fibres/ml = 1 mppcf, the slope of the line was 0.0076. The slope for plant 1 was 0.0003. Among all workers (the 6931, plus 167 early employees) ten mesotheliomas had occurred up to 1984: two from plant 1, eight from plant 2. In plant 2 a case-control analysis found a relation between risk of mesothelioma and duration of employment (p less than 0.01) and proportion of time spent in the pipe area (p less than 0.01), thus adding to the evidence of a greater risk of mesothelioma from crocidolite than chrysotile asbestos. A review of the mortality findings of eight cohorts of asbestos cement workers is presented.

Full text

PDF
161

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acheson E. D., Gardner M. J., Winter P. D., Bennett C. Cancer in a factory using amosite asbestos. Int J Epidemiol. 1984 Mar;13(1):3–10. doi: 10.1093/ije/13.1.3. [DOI] [PubMed] [Google Scholar]
  2. Alies-Patin A. M., Valleron A. J. Mortality of workers in a French asbestos cement factory 1940-82. Br J Ind Med. 1985 Apr;42(4):219–225. doi: 10.1136/oem.42.4.219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Berry G., Newhouse M. L. Mortality of workers manufacturing friction materials using asbestos. Br J Ind Med. 1983 Feb;40(1):1–7. doi: 10.1136/oem.40.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Berry G. The analysis of mortality by the subject-years method. Biometrics. 1983 Mar;39(1):173–184. [PubMed] [Google Scholar]
  5. Doll R. Occupational cancer: a hazard for epidemiologists. Int J Epidemiol. 1985 Mar;14(1):22–31. doi: 10.1093/ije/14.1.22. [DOI] [PubMed] [Google Scholar]
  6. Finkelstein M. M. Mortality among employees of an Ontario asbestos-cement factory. Am Rev Respir Dis. 1984 May;129(5):754–761. doi: 10.1164/arrd.1984.129.5.754. [DOI] [PubMed] [Google Scholar]
  7. Hammad Y. Y., Diem J., Weill H. Evaluation of dust exposure in asbestos cement manufacturing operations. Am Ind Hyg Assoc J. 1979 Jun;40(6):490–495. doi: 10.1080/15298667991429877. [DOI] [PubMed] [Google Scholar]
  8. Hanley J., Liddell D. Fitting relationships between exposure and standardized mortality ratios. J Occup Med. 1985 Aug;27(8):555–560. doi: 10.1097/00043764-198508000-00011. [DOI] [PubMed] [Google Scholar]
  9. Hughes J. M., Weill H. Asbestos exposure--quantitative assessment of risk. Am Rev Respir Dis. 1986 Jan;133(1):5–13. doi: 10.1164/arrd.1986.133.1.5. [DOI] [PubMed] [Google Scholar]
  10. Hughes J., Weill H. Lung cancer risk associated with manufacture of asbestos-cement products. IARC Sci Publ. 1980;(30):627–635. [PubMed] [Google Scholar]
  11. Jones J. S., Pooley F. D., Clark N. J., Owen W. G., Roberts G. H., Smith P. G., Wagner J. C., Berry G., Pollock D. J. The pathology and mineral content of lungs in cases of mesothelioma in the United Kingdom in 1976. IARC Sci Publ. 1980;(30):187–199. [PubMed] [Google Scholar]
  12. McDonald A. D., Fry J. S., Woolley A. J., McDonald J. C. Dust exposure and mortality in an American factory using chrysotile, amosite, and crocidolite in mainly textile manufacture. Br J Ind Med. 1983 Nov;40(4):368–374. doi: 10.1136/oem.40.4.368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. McDonald A. D., Fry J. S., Woolley A. J., McDonald J. Dust exposure and mortality in an American chrysotile textile plant. Br J Ind Med. 1983 Nov;40(4):361–367. doi: 10.1136/oem.40.4.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. McDonald A. D., McDonald J. C. Mesothelioma and asbestos fibre type. Br J Ind Med. 1985 Aug;42(8):567–568. doi: 10.1136/oem.42.8.567-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. McDonald A. D. Mineral fibre content of lung in mesothelial tumours: preliminary report. IARC Sci Publ. 1980;(30):681–685. [PubMed] [Google Scholar]
  16. Newhouse M. L., Berry G., Skidmore J. W. A mortality study of workers manufacturing friction materials with chrysotile asbestos. Ann Occup Hyg. 1982;26(1-4):899–909. [PubMed] [Google Scholar]
  17. Ohlson C. G., Hogstedt C. Lung cancer among asbestos cement workers. A Swedish cohort study and a review. Br J Ind Med. 1985 Jun;42(6):397–402. doi: 10.1136/oem.42.6.397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Thomas H. F., Benjamin I. T., Elwood P. C., Sweetnam P. M. Further follow-up study of workers from an asbestos cement factory. Br J Ind Med. 1982 Aug;39(3):273–276. doi: 10.1136/oem.39.3.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Weill H., Hughes J., Waggenspack C. Influence of dose and fiber type on respiratory malignancy risk in asbestos cement manufacturing. Am Rev Respir Dis. 1979 Aug;120(2):345–354. doi: 10.1164/arrd.1979.120.2.345. [DOI] [PubMed] [Google Scholar]
  20. Weill H., Waggenspack C., Bailey W., Ziskind M., Rossiter C. Radiographic and physiologic patterns among workers engaged in manufacture of asbestos cement products: a preliminary report. J Occup Med. 1973 Mar;15(3):248–252. [PubMed] [Google Scholar]
  21. Weill H., Ziskind M. M., Waggenspack C., Rossiter C. E. Lung function consequences of dust exposure in asbestos cement manufacturing plants. Arch Environ Health. 1975 Feb;30(2):88–97. doi: 10.1080/00039896.1975.10666650. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Industrial Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES